Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Brain Function in Insulin Resistant Elderly
NCT03733132Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Mar 2019
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in insulin resistance (IR), obesity, sponsored by Mayo Clinic. Started Mar 2019; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
insulin resistance (IR)obesity
Beyond the preview
Go deeper on NCT03733132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03733132.